Abstract

The Clinical Pharmacy Congress 2022 marked its 11th birthday, celebrating the return to normality after the pandemic with the delivery of over 250 educational sessions by industry experts over two days, to enhance the professional and personal development of attendees. Joy Ogden covers some highlights of the conference on thought‐provoking subjects such as risks of dementia with antimuscarinics and sessions on clinical priorities in epilepsy and headache.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.